(Q49135107)

English

Potential role for valproate in the treatment of high--risk brain tumors of childhood-results from a retrospective observational cohort study.

scientific article published on 24 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Potential role for valproate in the treatment of high--risk brain tumors of childhood-results from a retrospective observational cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

1 reference

based on heuristic

inferred from title

author name string

Francisco Helder Cavalcante Felix

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Nadia Mendonça Trompieri

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Orlandira Leite de Araujo

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Karine Martins da Trindade

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Juvenia Bezerra Fontenele

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

publication date

24 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

28

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

556-570

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

Chemotherapy for malignant brain tumors of childhood.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Recent development in chemotherapy of paediatric brain tumours

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Brainstem tumors: where are we today?

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Past, present, and future strategies in the treatment of high-grade glioma in children

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid for the treatment of pediatric malignant glioma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Epigenetic changes in gliomas

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Postradiation sensitization of the histone deacetylase inhibitor valproic acid

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Epigenetic silencing of the MGMT gene in cancer.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Vincristine--an effective treatment of corticoid-resistant life-threatening infantile hemangiomas.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Valproic acid inhibits angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563774

21 January 2018

Identifiers

10.3109/08880018.2011.563774

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

release_hcvnumh2hbfn7ertediz24ofte

1 reference

https://api.fatcat.wiki/v0/release/hcvnumh2hbfn7ertediz24ofte

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21699466

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49135107&oldid=1836335876"